Clinical Trial Update: Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 safety study of Rotavin-M1 in healthy adults has completed, documenting adverse events such as diarrhea, vomiting, fever, nausea, and irritability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Rotavin-M1 (Rotavirus vaccine, live attenuated)

Snippet

Sponsor: National Institute of Hygiene and Epidemiology, Vietnam | Conditions: Diarrhea, Vomit | Phase 1 | Status: COMPLETED